<ARTICLE>      5
<LEGEND>
               This schedule contains summary information
               extracted from the Statements of Operations and
               Balance Sheets of InVitro International and is
               qualified in its entirety by reference to such    
               financial statements.
</LEGEND>
<CIK>          0000872610
<NAME>         INVITRO INTERNATIONAL
<MULTIPLIER>   1000
                                  
<FISCAL-YEAR-END>           Sep-30-1996 
<PERIOD-START>              Oct-01-1995 
<PERIOD-END>                Mar-31-1996 
<PERIOD-TYPE>                     6-MOS 
<CASH>                            1,239 
<SECURITIES>                          0 
<RECEIVABLES>                       203 
<ALLOWANCES>                         15 
<INVENTORY>                         188 
<CURRENT-ASSETS>                    170 
<PP&E>                            1,010 
<DEPRECIATION>                      764 
<TOTAL-ASSETS>                     2,113 
<CURRENT-LIABILITIES>               309 
<BONDS>                               0 
<PREFERRED-MANDATORY>                 0 
<PREFERRED>                           0 
<COMMON>                         23,864 
<OTHER-SE>                       (22,060)
<TOTAL-LIABILITY-AND-EQUITY>      2,113 
<SALES>                             485 
<TOTAL-REVENUES>                    485 
<CGS>                               333 
<TOTAL-COSTS>                       941 
<OTHER-EXPENSES>                    (39)
<LOSS-PROVISION>                      0 
<INTEREST-EXPENSE>                    0 
<INCOME-PRETAX>                    (989)
<INCOME-TAX>                          0 
<INCOME-CONTINUING>                (989)
<DISCONTINUED>                        0 
<EXTRAORDINARY>                       0 
<CHANGES>                             0 
<NET-INCOME>                       (989)
<EPS-PRIMARY>                     (0.08)
<EPS-DILUTED>                     (0.08)